LVL. D. Vorona

L. D. Vorona

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


L. D. Vorona has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Congenital infection caused by lymphocytic choriomeningitis virus: little-known problem in modern perinatal medicine

    by H. A. Sarkisyan, L. D. Vorona, D. M. Muscherova, A. I. Vavilova, K. S. Zizyukina, A. I. Krapivkin, P. V. Shumilov

    Congenital infections play a significant role in perinatal pathology. Of particular interest is the lymphocytic choriomeningitis virus (Lymphocytic choriomeningitis, ICD-10: A87.2), which has pronounced neurotropic and teratogenic effects. Congenital infection caused by the lymphocytic choriomeningitis virus is characterized by microcephaly, hydrocephalus, periventricular calcifications, and visual and auditory lesions. Diagnosis is based on the identification of characteristic structural abnormalities during prenatal screening ultrasound and confirmation of the viral etiology of the disease. Specific antiviral drugs and vaccines against the lymphocytic choriomeningitis virus are currently unavailable, so treatment is supportive. Approximately one-third of newborns die in infancy, and survivors develop persistent neurological and ophthalmological disorders. Given the underestimated prevalence of this virus, this work aims to systematize current data on the pathogenesis, clinical features, diagnosis, and prognosis of congenital infection caused by the lymphocytic choriomeningitis virus.

  • Nonsyndromic and syndromic craniosynostosis in neonatal practice: similarities and differences

    by P. R. Deryugina, H. A. Sarkisyan, L. D. Vorona, E. S. Sakharova, K. S. Zizyukina, D. M. Muscherova, Yu. L. Ishutina, A. I. Krapivkin, P. V. Shumilov

    Craniosynostoses (ICD - 10: Q75.0) is a heterogeneous group of pathologies characterized by premature fusion of cranial sutures, including isolated (non-syndromic) and syndromic forms associated with genetic syndromes and multiple developmental abnormalities. The aim of the study was to identify clinical markers of craniosynostosis for timely diagnosis, determination of medical support tactics and improvement of prognostic criteria. Materials and Methods . A retrospective analysis of the data of 31 children with a verified diagnosis of craniosynostosis was performed. The patients were divided into 2 groups: Group I – 20 children with non–syndromic and group II - 11 people with syndromic forms of craniosynostosis. A comparative analysis of anamnestic, anthropometric data, gender and age characteristics, the presence of craniofacial dysmorphism, and concomitant pathology was carried out. Results . Non-syndromic forms of craniosynostosis were characterized by an isolated lesion of one cranial suture (90% of cases), male patients predominated among this group (60% of cases). For the syndromic forms of craniosynostosis, polysynostosis turned out to be pathognomonic (81,8% of cases) with the obligatory involvement of a coronary suture (90,9%), female patients prevailed (63,6%). Malformations of the central nervous system were diagnosed exclusively in group II (100% of patients), and abnormalities of the genitourinary system were diagnosed only in group I (40%). Limb defects were more common in group II compared with group I (72,7% and 10—15%, respectively). Pathology of the perinatal period in group II is respiratory disorders due to congenital pneumonia. A molecular genetic study showed that in group II, 10 children had mutations in the FGFR2 gene, and one child with the Pfeiffer phenotype had a mutation in the FGFR1 gene. Conclusion . The differential diagnostic criteria of the syndromic forms are polysynostosis, malformations of the central nervous system and limbs in combination with pathology of the perinatal period. The detection of concomitant anomalies in patients with cranial deformity is an indication for an in-depth medical and genetic examination.

  • Open Access

    A rare case of craniosynostosis: Pfeiffer-like syndrome in a neonatologist’s practice

    by D. M. Muscherova, H. A. Sarkisyan, L. D. Vorona, A. B. Smolyannikova, P. R. Deryugina, K. S. Zizyukina, Yu. L. Ishutina, A. I. Krapivkin, P. V. Shumilov, Е. А. Саркисян

    Craniosynostoses (ICD-10: Q75.0) are pathological conditions associated with premature closure of the cranial sutures, resulting in cranial deformity, restricted brain growth and, without timely intervention, severe neurological disorders. They also correlate closely with various syndromal pathologies and are manifested by the presence of additional malformations in patients. Diagnostic difficulty is represented by situations when, in the presence of all phenotypic features of syndromal craniosynostosis, it is not possible to identify a genetic mutation, which requires a more thorough examination and a broad differential diagnosis. In the following clinical observation, we describe a unique case of Pfeiffer-like syndrome in a child with no identified characteristic genetic mutation and a favourable prognosis for life.

  • Surfactant and surfactant therapy in neonates: from the beginning to the modern features of the application

    by K. S. Zizyukina, H. A. Sarkisyan, L. D. Vorona, L. A. Levchenko, E. I. Shabelnikova, A. P. Khokhlova, Sh. T. Abasova, P. V. Shumilov, Е. А. Саркисян

    Surfactant is a secreted surface-active substance that provides the first breath of the newborn by reducing the surface tension of the alveoli. Surfactant preparations were the first and most popular drugs in neonatology, saving the lives of millions of premature babies. Successful treatment with surfactants is preceded by an individual personalized approach to each child and early detection of newborns with surfactant deficiency. Determining the indications for surfactant therapy, choosing an effective method of drug delivery, selecting concomitant respiratory support are current areas of neonatology to this day. The article reflects the history of use, new approaches to surfactant therapy and methods of administration of various surfactant preparations.


  • Clinical case report of diaphanospondylodysostosis, a rare skeletal dysplasia, in a newborn

    by L.D. Vorona, T.I. Meshcheryakova, T.V. Kozhanova, Yu.L. Ishutina, Ya.S. Solovyova, S.S. Zhilina, A.G. Prityko

    Diaphanospondylodysostosis is a rare genetic skeletal disorder caused by biallelic variants in the BMPER gene. The term “diaphanospondylodysostosis” includes ischiospinal dysotosis, which was previously known as a separate entity with milder clinical features. The clinical phenotype of diaphanospondylodysostosis is quite variable and some cases have been lethal in the early postnatal period. The main clinical and radiographic features of the disease are a narrow chest, segmentation defects of the spine, rib anomalies, decreased ossification of the axial skeleton and nephrogenic cysts. Authors represent a clinical case report of a newborn female with diaphanospondylodysostosis who was found to have two novel heterozygous variants in the bone morphogenetic protein endothelial progenitor-binding regulator (BMPER) gene.

  • Early manifestations of combined mutations in the PACS1 and HFS4 genes in a newborn with Schuurs-Hoeijmakers syndrome

    by V.A. Mironova, K.S. Zizyukina, H.A. Sarkisyan, L.D. Vorona, T.V. Kozhanova, E.A. Veselova, N.S. Kolyadov, M.A. Ovsyannikova, T.I. Meshcheryakova, A.I. Krapivkin, et al.

    Schuurs-Hoeijmakers syndrome (OMIM: 615009), or PACS1 neurodevelopmental disorder (PACS1-NDD), is a rare autosomal dominant disease caused by a mutation in the PACS1 gene, characterized by intellectual disability and distinctive facial dysmorphism. The literature describes approximately 65 patients with Schuurs-Hoeijmakers syndrome aged 2 to 21 years. In current medicine, there is very little information about the features of Schuurs-Hoeijmakers syndrome in the neonatal period, as well as other manifestations when several significant mutations are detected. This article presents a clinical case of Schuurs-Hoeijmakers syndrome diagnosed in early childhood in a patient with combined mutations in the PACS1 and HFS4 genes. Key words: Schuurs-Hoeijmakers syndrome, PACS1 protein, HSF4 gene mutation, congenital cataract, hypotonia, coloboma, congenital heart defect

  • Congenital Zika virus infection: an emerging challenge in perinatal medicine

    by H.A. Sarkisyan, L.D. Vorona, A.I. Vavilova, A.P. Khokhlova, V.I. Kozodaeva, P.V. Shumilov

    Congenital Zika syndrome (CZS) is caused by a flavivirus and is characterized by various clinical manifestations, the most common of which are congenital brain and eye malformations. The first mention of Zika virus (Zika-virus, A92.5) dates back to the 1940s. It is primarily transmitted through the bite of infected Aedes mosquitoes and can also be transmitted sexually, through blood and saliva. More recently, it has been found that Zika virus can pass from a pregnant woman to her fetus, causing congenital Zika syndrome (P35.4), intrauterine growth restriction and, in some cases, pregnancy loss. The risk of congenital neurological defects associated with Zika virus infection ranges from 6% to 42% in various reports. The similarity of clinical manifestations, as well as ontogenetic commonality with other infectious agents argue the need for differential diagnosis between congenital infection associated with Zika virus and infections caused by yellow fever, Dengue fever, Japanese encephalitis, West Nile fever, Chikungunya, and TORCH infections (rubella, toxoplasmosis, cytomegalovirus, etc.). In 2023, 89 countries have already reported Zika virus circulation in their territories, but sanitary surveillance worldwide remains limited. All of the above cannot but cause concern for specialists in perinatal medicine. This article presents relevant data on the clinical features, early and late complications of congenital Zika virus infection. Key words: congenital Zika syndrome, Zika virus, newborns, pregnancy, microcephaly, calcifications, arthrogryposis


  • Peculiarities of development and lesions of the central nervous system in late preterm newborns

    by I. V. Zhuravleva, I. Yu. Zyablova, E. A. Sarkisyan, L. D. Vorona, S. V. Dumova, E. I. Shabelnikova, I. N. Tulsky, P. V. Shumilov, И. Ю. Зяблова

    The last weeks of pregnancy are a critical period of intrauterine development of the central nervous system. In late preterm infants born at gestational age 340/7 — 366/7 weeks, the maturation of the central nervous system continues postnatally, which determines its high vulnerability to various pathologic effects. Morphofunctional immaturity and frequent complications of the neonatal period increase the likelihood of early brain lesions leading to further disorders of neuropsychiatric development. Even in the absence of clinically significant neurological abnormalities in the neonatal period, late preterm neonates have a risk of social-adaptive, behavioral, motor and cognitive impairments in later life. Predicting the outcome of central nervous system lesions in late preterm neonates is possible with the help of neuroimaging methods, as well as with the use of specialized tools to assess various areas of psychomotor development. Modern approaches to prevent neurological complications include prevention and treatment of hypoxia, hypoglycemia, hyperbilirubinemia, infections, provision of adequate nutritional support and adherence to vaccination in late preterm neonates.

  • Open Access

    A case of early neonatal sepsis caused by Streptococcus pneumoniae

    by S. V. Dumova, И. О. Кузьмина, O. L. Chugunova, S. I. Zhogin, D. V. Lychagina, O. G. Ni, V. V. Voronov, A. A. Khanmagomedova, L. D. Vorona, E. A. Sarkisyan, et al.

    The article presents a case of early neonatal sepsis in a premature neonate caused by Streptococcus pneumoniae with the development of purulent meningitis, describes the diagnostic possibilities and features of treatment, as well as the outcome of this condition in the child. In the presented case the rapid increase of symptoms of meningo-encephalitis, slow sanation of liquor, despite the adequacy of the conducted therapy, attracts attention.


  • Apert syndrome: modern aspects of diagnosis and treatment

    by S. S. Kantutis, E. A. Sarkisyan, P. V. Shumilov, L. D. Vorona, O. V. Pravoslavnaya, L. A. Levchenko, E. I. Shabelnikova, M. A. Sokolova, A. I. Krapivkin

    The purpose of this review is to raise awareness of medical professionals about the features of the clinical picture, the possibilities of diagnosis (including prenatal) and therapy of patients with Apert syndrome to further improve the prognosis and improve the quality of life. Acrocephalosyndactyly is a group of rare congenital syndromes characterized by the presence of acrocephaly, craniofacial anomalies, syndactyly of the hands and feet. According to the literature, the most common form of аcrocephalosyndactyly is Apert syndrome (acrocephalosyndactyly type I, Apert syndrome, ICD 10 Q 87.0, OMIM 101200). This is a genetic disease inherited by an autosomal dominant type. CA is caused by a mutation of the fibroblast growth factor receptor type 2 gene (FGFR2) located on the long arm of chromosome 10, which leads to increased bone metabolism and impaired bone synthesis. The frequency of Apert syndrome is about 15 cases per 1,000,000 live births. Wheaton first reported this pathology in 1894, and in 1906 the French pediatrician Eugene Apert published a series of nine clinical cases with a characteristic triad of symptoms. Apert syndrome is characterized by craniosynostosis, bilateral symmetrical limb syndactyly and dysmorphic facial features. Hypoplasia of the upper jaw and bicoronal synostosis are two noticeable craniofacial defects that lead to a flat, deepened appearance of the forehead and the middle part of the face. Hypertelorism and excessive orbitality, low-set ears, flat nose and cleft palate are often found. Cardiovascular, neurological and genitourinary abnormalities may be present. Diagnosis is based on clinical criteria and molecular genetic testing. There is a possibility of prenatal detection of Apert syndrome.